EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 336 filers reported holding EXELIXIS INC in Q4 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $67,000 | -10.7% | 3,208 | -3.6% | 0.01% | 0.0% |
| Q1 2022 | $75,000 | +971.4% | 3,327 | +731.8% | 0.01% | +600.0% |
| Q1 2020 | $7,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $7,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $7,000 | -22.2% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $9,000 | -10.0% | 400 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $10,000 | +25.0% | 400 | 0.0% | 0.00% | -66.7% |
| Q4 2018 | $8,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |